Aspire Private Capital’s AstraZeneca AZN Stock Holding History

Aspire Private Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-126	Closed	-$19.6K	–	202
2024 Q3	$19.6K	Hold	126	–	–	﹤0.01%	306
2024 Q2	$19.6K	Hold	126	–	–	0.01%	317
2024 Q1	$17K	Hold	126	–	–	﹤0.01%	340
2023 Q4	$16.9K	Hold	126	–	–	0.01%	340
2023 Q3	$17K	Hold	126	–	–	0.01%	334
2023 Q2	$18K	Hold	126	–	–	0.01%	303
2023 Q1	$17.5K	Sell	126 -2	-2%	-$269	0.01%	301
2022 Q4	$17.4K	Hold	128	–	–	0.01%	307
2022 Q3	$14K	Sell	128 -1	-0.8%	-$127	0.01%	308
2022 Q2	$17K	Hold	129	–	–	0.01%	288
2022 Q1	$17K	Hold	129	–	–	0.01%	295
2021 Q4	$15K	Sell	129 -2	-2%	-$235	﹤0.01%	300
2021 Q3	$16K	Buy	131 +27	+26%	+$3.14K	0.01%	280
2021 Q2	$12K	Hold	104	–	–	﹤0.01%	306
2021 Q1	$10K	Hold	104	–	–	﹤0.01%	328
2020 Q4	$10K	Hold	104	–	–	﹤0.01%	266
2020 Q3	$11K	Buy	+104	New	+$11.6K	﹤0.01%	269
2020 Q2	–	Sell	-4	Closed	–	–	296
2020 Q1	$0	Sell	4 -114	-97%	-$10.7K	﹤0.01%	249
2019 Q4	$12K	Buy	118 +4	+4%	+$377	0.01%	254
2019 Q3	$10K	Hold	114	–	–	﹤0.01%	251
2019 Q2	$9K	Buy	114 +10	+10%	+$784	﹤0.01%	274
2019 Q1	$8K	Sell	104 -3,690	-97%	-$291K	﹤0.01%	328
2018 Q4	$288K	Buy	+3,794	New	+$296K	0.17%	100

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Aspire Private Capital's AZN Position: Q4 2024 in Review

Aspire Private Capital sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 126 shares — an estimated $19.6K sold.

Aspire Private Capital first reported a position in AZN in Q4 2018 and held it in 23 quarters. The position peaked at $288K in Q4 2018. 1,220 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

Aspire Private Capital reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
Aspire Private Capital sold 126 AstraZeneca shares in Q4 2024, an estimated $19.6K.
Aspire Private Capital first reported a position in AstraZeneca in Q4 2018 and held it in 23 quarters.
Aspire Private Capital's AstraZeneca position peaked at $288K in Q4 2018.
1,220 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.